Ftse Mib
33.645,43
-0,27%
DAX
18.001,60
0,54%
S&P 500
5.121,65
1,13%
NASDAQ
16.156,37
1,99%
Bitcoin
61.710,90
4,38%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ocular Therapeutix Inc (OCUL) Ocular Therapeutix Inc (OCUL) Notizie

Ocular Therapeutix Inc

OCUL
6,29
0,42 (7,16%)
Ultimo aggiornamento: 18:44:13
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202413:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01/5/202413:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
11/3/202421:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202421:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:10EDGAR2Form 8-K - Current report
11/3/202411:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
27/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202402:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/2/202402:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202414:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202413:34EDGAR2Form 8-K - Current report
19/2/202415:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15/2/202414:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
15/2/202401:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202413:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
07/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:41EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:39EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:36EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:33EDGAR2Form 144 - Report of proposed sale of securities
05/2/202422:30EDGAR2Form 144 - Report of proposed sale of securities
03/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:41EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:39EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:36EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:34EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:31EDGAR2Form 144 - Report of proposed sale of securities
25/1/202414:04EDGAR2Form 8-K - Current report
28/12/202322:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/12/202322:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202322:52EDGAR2Form SC 13D/A - General statement of acquisition of..
18/12/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:01GLOBEOcular Therapeutix™ Announces Closing of Public Offering of..
14/12/202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202314:46EDGAR2Form 8-K - Current report
14/12/202304:09GLOBEOcular Therapeutix™ Announces Pricing of Public Offering of..
14/12/202301:07DJNStocks to Watch: Adobe, Amtech Systems, Ocular Therapeutix
13/12/202322:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202322:01GLOBEOcular Therapeutix™ Announces Proposed Public Offering of..
17/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
Apertura: 6,06 Min: 6,03 Max: 6,34
Chiusura: 5,87

La tua Cronologia

NASDAQ
OCUL
Ocular Therapeutix
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network